Wednesday, 25 Apr 2018

You are here

EMA to Review Methotrexate Overdose and Dosing Errors

A recent meeting (April 9-12) of the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) considered the problem of dosing errors with methotrexate (MTX), citing "continued reports of overdose." 

Although usually dosed at low doses,  given weekly (for rheumatoid arthritis; higher in some malignancies), the EMA has noted reports of improper MTX dosing that has lead to fatal or serious outcomes in some reports. Prompted by the Spanish medicines regulator, AEMPS, the PRAC was asked to investigate why dosing errors continue with MTX.  

There has been sporadic reports of MTX dosing errors for years, but the EMA notes that measures to reduce this risk are unclear.

Medscape reports that the PRAC will examine the evidence and make recommendations to the Committee for Medicinal Products for Human Use, on how to minimize this risk. (Citation souce:  https://wb.md/2H2Et46)

Severe toxicity from MTX may include mucosal or gastrointestinal tract ulceration, liver toxicity, bone marrow suppression, septicemia, or death.  Risk factors for MTX overdose/toxicity typically include renal insufficiency (or sudden decline in renal function), hypoalbuminemia, dosing errors (use of higher than recommended doses) and failure to use folate supplementation.

Several recent reports underscore the serious consequences of rarely seen MTX dosing errors. 

  • Ajmani et al reported on 46 cases of MTX induced severe pancytopenia observed over a 19 year period. They noted a high mortality rate (13/46) and that the presenting symptoms may be high fever and severe mucositis. Common features included: oral mucositis (n = 37); fever (24); diarrhea (12), bleeding gums (5) and purpura (3). http://bit.ly/2JLjXa5 
  • A study of 4 different Danish registers identified 173 errors with nearly two-thirds resulting in harm. Serious harm occurred in 15% and there were 9 deaths (5%). These involved involved incorrect daily administration (31%), dosing errors (62%) and 9% had improper \monitoring. Prescription errors involving daily rather than weekly administration, by hospital physicians, were most likely to result in serious outcomes, including deaths. http://bit.ly/2JLlxZz
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Tobacco Associated Deaths in the USA

JAMA Internal Medicine reports that in the USA, those who smoke cigar, pipe, or cigarette have a significant overall  mortality risk, and a much highers cancer mortality risk compared to nonsmokers.

The National Longitudinal Mortality Study collected baseline survey data from 1985 through 2011 and included 357,420 participants reporting on their use of cigar, pipes, or cigarettes.

MMWR: Cannabis Use in the Colorado Workers

MMWR reports that eight states, including Colorado, have legalized recreational marijuana for use by adults and that a study of use in Colorado has shown that nearly 15% of Colorado adult workers have used marijuana in the past 30 days. Use was highest among young adults, especially men, working in the Accommodation/Food Services and Food Preparation/Serving industries.

2 Weeks Off Methotrexate OK for Flu Vaccine

Stopping methotrexate for 2 weeks after the administration of flu vaccine led to improved immunogenicity without increasing disease activity among patients with rheumatoid arthritis (RA), a prospective Korean study showed.

Risk of Paternal Exposure to Anti-Rheumatic Drugs

Seminars in Arthritis and Rheumatism features a review of the effects of paternal use of antirheumatic drugs on pregnancy, specifically addressing the effects of NSAIDs, steroids, DMARDs and biologics on spermatogenesis and the effect on pregnancy outcomes and offspring.

Repeat Malignancy Unlikely with Biologic Therapy

Research from the Danish biologics registry shows that the use of a biologic in patients with a history of a primary cancer does not increase the risk of a second malignant neoplasm (SMN) or mortality in rheumatoid arthritis (RA) patients.

They analyzed 15,286 RA patients in the DANBIO Register between 2000–2011 and found 1678 with a primary cancer.  The majority (1203) did not use biologics after.